141 related articles for article (PubMed ID: 16705717)
1. Inhibition of IKK activation, through sequestering NEMO, blocks PMMA-induced osteoclastogenesis and calvarial inflammatory osteolysis.
Clohisy JC; Yamanaka Y; Faccio R; Abu-Amer Y
J Orthop Res; 2006 Jul; 24(7):1358-65. PubMed ID: 16705717
[TBL] [Abstract][Full Text] [Related]
2. Erythromycin inhibits wear debris-induced inflammatory osteolysis in a murine model.
Ren W; Wu B; Peng X; Mayton L; Yu D; Ren J; Chen BD; Wooley PH
J Orthop Res; 2006 Feb; 24(2):280-90. PubMed ID: 16435361
[TBL] [Abstract][Full Text] [Related]
3. Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways.
Hu JP; Nishishita K; Sakai E; Yoshida H; Kato Y; Tsukuba T; Okamoto K
Eur J Pharmacol; 2008 Feb; 580(1-2):70-9. PubMed ID: 18083161
[TBL] [Abstract][Full Text] [Related]
4. Polyubiquitination events mediate polymethylmethacrylate (PMMA) particle activation of NF-kappaB pathway.
Yamanaka Y; Karuppaiah K; Abu-Amer Y
J Biol Chem; 2011 Jul; 286(27):23735-41. PubMed ID: 21566132
[TBL] [Abstract][Full Text] [Related]
5. The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis.
Dai S; Hirayama T; Abbas S; Abu-Amer Y
J Biol Chem; 2004 Sep; 279(36):37219-22. PubMed ID: 15252035
[TBL] [Abstract][Full Text] [Related]
6. Mitogen-activated protein (MAP) kinases mediate PMMA-induction of osteoclasts.
Abbas S; Clohisy JC; Abu-Amer Y
J Orthop Res; 2003 Nov; 21(6):1041-8. PubMed ID: 14554217
[TBL] [Abstract][Full Text] [Related]
7. Map kinase c-JUN N-terminal kinase mediates PMMA induction of osteoclasts.
Yamanaka Y; Abu-Amer Y; Faccio R; Clohisy JC
J Orthop Res; 2006 Jul; 24(7):1349-57. PubMed ID: 16732613
[TBL] [Abstract][Full Text] [Related]
8. Lysine392, a K63-linked ubiquitination site in NEMO, mediates inflammatory osteoclastogenesis and osteolysis.
Alhawagri M; Yamanaka Y; Ballard D; Oltz E; Abu-Amer Y
J Orthop Res; 2012 Apr; 30(4):554-60. PubMed ID: 21913221
[TBL] [Abstract][Full Text] [Related]
9. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
10. NF-kappaB modulators in osteolytic bone diseases.
Xu J; Wu HF; Ang ES; Yip K; Woloszyn M; Zheng MH; Tan RX
Cytokine Growth Factor Rev; 2009 Feb; 20(1):7-17. PubMed ID: 19046922
[TBL] [Abstract][Full Text] [Related]
11. NEMO binding domain of IKK-2 encompasses amino acids 735-745.
Strnad J; McDonnell PA; Riexinger DJ; Mapelli C; Cheng L; Gray H; Ryseck RP; Burke JR
J Mol Recognit; 2006; 19(3):227-33. PubMed ID: 16583354
[TBL] [Abstract][Full Text] [Related]
12. Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway.
Tsai HY; Lin HY; Fong YC; Wu JB; Chen YF; Tsuzuki M; Tang CH
Eur J Pharmacol; 2008 Jun; 588(1):124-33. PubMed ID: 18495114
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of NF-kappaB in dendritic cells by the NEMO-binding domain peptide blocks maturation and prevents T cell proliferation and polarization.
Tas SW; de Jong EC; Hajji N; May MJ; Ghosh S; Vervoordeldonk MJ; Tak PP
Eur J Immunol; 2005 Apr; 35(4):1164-74. PubMed ID: 15770694
[TBL] [Abstract][Full Text] [Related]
14. Impediment of NEMO oligomerization inhibits osteoclastogenesis and osteolysis.
Darwech I; Otero J; Alhawagri M; Dai S; Abu-Amer Y
J Cell Biochem; 2009 Dec; 108(6):1337-45. PubMed ID: 19830703
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand.
Wilson TJ; Nannuru KC; Futakuchi M; Sadanandam A; Singh RK
Cancer Res; 2008 Jul; 68(14):5803-11. PubMed ID: 18632634
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of NEMO, the regulatory subunit of the IKK complex, induces apoptosis in high-risk myelodysplastic syndrome and acute myeloid leukemia.
Carvalho G; Fabre C; Braun T; Grosjean J; Ades L; Agou F; Tasdemir E; Boehrer S; Israel A; Véron M; Fenaux P; Kroemer G
Oncogene; 2007 Apr; 26(16):2299-307. PubMed ID: 17043643
[TBL] [Abstract][Full Text] [Related]
17. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.
Mohamed SG; Sugiyama E; Shinoda K; Taki H; Hounoki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Ogawa H; Miyahara T
Bone; 2007 Oct; 41(4):592-602. PubMed ID: 17627913
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of titanium particle-induced osteoclastogenesis through inactivation of NFATc1 by VIVIT peptide.
Liu F; Zhu Z; Mao Y; Liu M; Tang T; Qiu S
Biomaterials; 2009 Mar; 30(9):1756-62. PubMed ID: 19118894
[TBL] [Abstract][Full Text] [Related]
20. Blockade of NF-κB and MAPK pathways by ulinastatin attenuates wear particle-stimulated osteoclast differentiation in vitro and in vivo.
Ru JY; Xu HD; Shi D; Pan JB; Pan XJ; Wang YF
Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27638499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
